Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Isoprenaline

Isoprenaline: A Comprehensive Overview

Introduction

Isoprenaline, also known by its international nonproprietary name (INN) as Isoproterenol, is a synthetic sympathomimetic amine and non-selective beta-adrenergic agonist. It plays a crucial role in emergency medicine, cardiology, and even pulmonology due to its potent ability to stimulate beta receptors, thereby influencing heart rate, bronchodilation, and vascular tone. Isoprenaline has historically been pivotal in the management of bradyarrhythmias, heart block, and even asthma. Although newer and more selective agents have replaced it in some applications, it remains an essential medication in several critical care scenarios.

Pharmacological Profile

1. Chemical and Structural Properties

  • IUPAC Name: 4-[1-Hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol

  • Molecular Formula: C11H17NO3

  • Molecular Weight: 211.26 g/mol

  • Routes of Administration: Intravenous (IV), intramuscular (IM), subcutaneous (SC), and inhalation.

Structurally, isoprenaline is a derivative of catecholamine, with similarities to epinephrine and norepinephrine. Its isopropyl group confers specificity to beta-adrenergic receptors over alpha receptors.

Mechanism of Action

Isoprenaline is a non-selective beta-adrenergic agonist, meaning it stimulates both beta-1 and beta-2 adrenergic receptors.

  • Beta-1 stimulation (predominantly in the heart): Increases heart rate (positive chronotropic effect), increases cardiac contractility (positive inotropic effect), and accelerates conduction through the AV node.

  • Beta-2 stimulation (in the lungs and vasculature): Causes bronchodilation and vasodilation, leading to decreased peripheral vascular resistance.

Unlike norepinephrine and epinephrine, isoprenaline has negligible alpha-adrenergic activity, so it does not cause vasoconstriction.

Pharmacokinetics

  • Onset of Action: Rapid when given intravenously.

  • Half-Life: Approximately 2.5 to 5 minutes.

  • Metabolism: Primarily metabolized by catechol-O-methyltransferase (COMT) in the liver and other tissues.

  • Excretion: Renal.

Due to its short half-life, continuous infusion is often necessary for sustained effects in emergency settings.

Clinical Uses

1. Bradyarrhythmias and Heart Block

Isoprenaline is particularly effective in treating bradycardia and atrioventricular (AV) block when temporary pacing is not immediately available. It increases heart rate and improves cardiac output in patients with symptomatic bradycardia.

2. Torsades de Pointes

While magnesium is the first-line treatment, isoprenaline can be used to increase heart rate and shorten the QT interval, thereby preventing recurrence in torsades de pointes, especially when the condition is drug-induced or due to long QT syndrome.

3. Bronchospasm and Asthma

Historically, isoprenaline was used via inhalation for bronchodilation in asthma and chronic obstructive pulmonary disease (COPD). However, due to risks of tachycardia and the availability of more selective beta-2 agonists like salbutamol, its use for this indication has waned.

4. Cardiac Arrest (Adjunct)

Though not a first-line agent, isoprenaline may be considered in specific scenarios like pulseless electrical activity (PEA) or asystole, especially if due to beta-blocker overdose, as it can help stimulate myocardial activity.

5. Beta-blocker Overdose

In severe beta-blocker toxicity, isoprenaline can help overcome beta-receptor blockade due to its high beta agonist activity. It is used alongside glucagon and other supportive measures.

6. Stress Testing

In some specialized cases, isoprenaline is used during cardiac stress testing when exercise is not feasible, as it can mimic the effects of exertion on the heart.

Dosage and Administration

Intravenous Infusion

  • Initial dose: 0.01 to 0.02 mcg/kg/min

  • Titrate based on heart rate and blood pressure

  • Max dose can vary but is usually ≤ 0.2 mcg/kg/min

Inhalation (historical use)

  • Delivered via nebulizer at concentrations of 0.25% or 0.5%

Administration must always be monitored closely, ideally in an intensive care or high-dependency setting, given the potential for rapid hemodynamic changes.

Side Effects

Isoprenaline is a powerful drug, and with its benefits come risks. Common and serious side effects include:

Cardiovascular

  • Tachycardia

  • Palpitations

  • Arrhythmias

  • Angina pectoris

  • Increased myocardial oxygen demand

  • Ventricular fibrillation (rare but serious)

CNS

  • Headache

  • Nervousness

  • Tremor

  • Anxiety

Respiratory

  • Dyspnea (in overdose)

Other

  • Nausea

  • Sweating

  • Hypokalemia (due to beta-2 mediated intracellular potassium shift)

Contraindications and Precautions

Contraindications

  • Tachyarrhythmias

  • Digitalis intoxication

  • Angina pectoris

  • Hypersensitivity to isoprenaline

Caution In

  • Elderly patients

  • Patients with coronary artery disease (CAD)

  • Hyperthyroidism

  • Hypertension

  • Diabetes mellitus

Close ECG and vital sign monitoring is essential during administration.

Drug Interactions

  • MAO inhibitors and tricyclic antidepressants: May potentiate the effects of isoprenaline.

  • Beta-blockers: Antagonize the action of isoprenaline.

  • Inhaled anesthetics: May sensitize the myocardium to beta-agonists, increasing the risk of arrhythmias.

  • Diuretics: Combined use may lead to electrolyte imbalance and increase arrhythmia risk.

Special Populations

Pediatric Use

  • Used with caution; dosing must be precise.

  • Monitoring is essential due to rapid pharmacokinetics.

Pregnancy

  • Category C: Use only if benefits justify potential risks.

Geriatrics

  • May be more susceptible to adverse effects such as arrhythmias.

Storage and Handling

  • Protect from light and heat.

  • Store at room temperature.

  • IV preparations must be diluted before infusion and used within a short period once prepared.

Advances and Alternatives

While isoprenaline was once a mainstay in many emergency medicine protocols, it has largely been replaced by more selective agents:

  • Dobutamine: More beta-1 selective, used in heart failure.

  • Salbutamol and Formoterol: Highly selective beta-2 agonists for asthma.

  • Adrenaline (Epinephrine): Preferred in anaphylaxis and cardiac arrest.

However, isoprenaline’s specific pharmacologic profile makes it valuable in scenarios like AV block and beta-blocker overdose where a potent beta-agonist is required.

Research and Future Prospects

New research continues to explore isoprenaline’s role in:

  • Genetic long QT syndromes

  • Electrophysiological studies and arrhythmia induction

  • Noninvasive pacing in pediatric and neonatal bradycardia

The push towards precision medicine and personalized care may yet revive interest in this old but gold drug in select populations.

Conclusion

Isoprenaline remains a potent, fast-acting beta-adrenergic agonist with unique clinical utility in emergency cardiology and resuscitation. Though its use has become more niche over time due to the advent of newer, more selective beta agonists, it still holds a firm place in specific, often life-threatening, clinical scenarios. Understanding its pharmacology, benefits, and potential risks allows healthcare professionals to use isoprenaline safely and effectively, ensuring better outcomes for patients in critical conditions. Its enduring presence on emergency trolleys and in ICUs underscores its importance in modern medicine.